Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings yield is N/A as of 2026-10-06T18:58:03.449Z.
Calculation as of: 2026-10-06T18:58:03.449Z.
Quote observation: 2026-10-06T18:55:03.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 7a3ccde1bd0df5c55ebc0148063105fff0bf751cb52a3071af3e3331f6001fbe
EARNINGS YIELD
N/A
Market Cap
$500.75M
Earnings Yield
4.86%
TTM Avg
3.42%
3Y Avg
5.62%
5Y Avg
4.98%
Market Cap
$488.92M
Earnings Yield
5.37%
TTM Avg
9.76%
3Y Avg
11.41%
5Y Avg
9.78%
Market Cap
$509.90M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Oculis Holding AG (OCS) | $495.66M | N/A | N/A | N/A | N/A |
| Tactile Systems Technology, Inc. (TCMD)vs › | $500.75M | 4.86% | 3.42% | 5.62% | 4.98% |
| Puma Biotechnology, Inc. (PBYI)vs › | $488.92M | 5.37% | 9.76% | 11.41% | 9.78% |
| Evolus, Inc. (EOLS)vs › | $486.67M | N/A | N/A | N/A | N/A |
| Allogene Therapeutics, Inc. (ALLO)vs › | $509.90M | N/A | N/A | N/A | N/A |
| 908 Devices Inc. (MASS)vs › | $508.74M | N/A | 8.34% | 8.34% | 8.34% |
| Crescent Biopharma, Inc. (CBIO)vs › | $514.07M | N/A | N/A | N/A | N/A |
| Arvinas, Inc. (ARVN)vs › | $474.91M | 2.17% | 1.86% | 1.86% | 1.86% |
| Cerus Corporation (CERS)vs › | $474.59M | N/A | 5.12% | 5.12% | 5.12% |
| Alpha Teknova, Inc. (TKNO)vs › | $474.22M | N/A | 0.09% | 0.09% | 0.09% |
Earnings Yield
N/A
EPS ÷ Price
P/E Ratio
N/A
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
